Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...